Program

22
14
1

Journal Year Published

8
5
9
7
7
2
1
7

Author

46
212
185
156
149
137
135
129
127
108
107
96
83
79
70
70
63
53
50
46

Category

25
11
5
5
3
1
1

Keyword

11
8
5
4
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2

Journal

7
3
3
3
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1

NCATS Publications

The Platform Vector Gene Therapies Project: Increasing the Efficiency of Adeno-Associated Virus Gene Therapy Clinical Trial Startup.


Brooks P, Ottinger E, Portero D, Lomash RM, Alimardanov A, Terse P, Xu X, Chandler RJ, Geist Hauserman J, Esposito E, Bönnemann CG, Venditti CP, Austin C, Pariser A, Lo D


Hum Gene Ther , (31), 1034-1042, 2020.

Article Pubmed

Sample image from publication page

Fluoxazolevir inhibits hepatitis C virus infection in humanized chimeric mice by blocking viral membrane fusion.


Ma CD, Imamura M, Talley DC, Rolt A, Xu X, Wang A, Le D, Uchida T, Osawa M, Teraoka Y, Li K, Hu X, Park SB, Chalasani N, Irvin PH, Dulcey Garcia A, Southall N, Marugan J, Hu Z, Chayama K, Frankowski KJ, Liang TJ


Nat Microbiol , (5), 1532-1541, 2020.

Article Pubmed

Sample image from publication page

Metabolism and pharmacokinetics characterization of metarrestin in multiple species.


Carvalho Padilha E, Shah P, Wang A, Singleton MD, Hughes EA, Li D, Rice KA, Konrath KM, Patnaik S, Marugan J, Rudloff U, Xu X


Cancer Chemother. Pharmacol. , (85), 805-816, 2020.

Article Pubmed

Sample image from publication page

Targeting AML-associated FLT3 mutations with a type I kinase inhibitor.


Jones LM, Melgar K, Bolanos L, Hueneman K, Walker MM, Jiang J, Wilson K, Zhang X, Shen J, Jiang F, Sutter P, Wang A, Xu X, Tawa G, Hoyt S, Wunderlich M, O'Brien E, Perentesis JP, Starczynowski DT, Thomas C


J. Clin. Invest. , (130), 2017-2023, 2020.

Article Pubmed

Sample image from publication page

Anxiolytic Drug FGIN-1-27 Ameliorates Autoimmunity by Metabolic Reprogramming of Pathogenic Th17 Cells.


Singh A, Dashnyam M, Chim B, Escobar TM, Dulcey AE, Hu X, Wilson K, Koganti PP, Spinner CA, Xu X, Jadhav A, Southall N, Marugan J, Selvaraj V, Lazarevic V, Muljo SA, Ferrer-Alegre M


Sci Rep , (10), 3766, 2020.

Article Pubmed

Sample image from publication page

Phosphocyclocreatine is the dominant form of cyclocreatine in control and creatine transporter deficiency patient fibroblasts.


Gorshkov K, Wang A, Sun W, Fisher E, Frigeni M, Singleton M, Thorne N, Class B, Huang W, Longo N, Do MT, Ottinger E, Xu X, Zheng W


Pharmacol Res Perspect , (7), e00525, 2019.

Article Pubmed

Sample image from publication page

Quantitation of cytidine-5'-monophospho-N-acetylneuraminic acid in human leukocytes using LC-MS/MS: method development and validation.


Fang M, Xu X, Zhang M, Shi Y, Gu G, Liu W, Class B, Ciccone C, Gahl WA, Huizing M, Carrillo N, Wang A


Biomed. Chromatogr. , (34), e4735, 2020.

Article Pubmed

Sample image from publication page